Add BrightSurf on Google Email

Science News Archive March 2009 - Page 3


Page 3 of 26

New link in liver cancer

A study found that removing a protective protein called STAT5 from liver cells leads to an overabundance of TGFbeta, a damage-inducing protein. This results in the activation of a cancer-promoting protein, STAT3, which can promote tumor growth.

SourceRockefeller University Press·JournalJournal of Experimental Medicine·DateMar 30, 2009

A milestone toward ending river blindness in the Western Hemisphere by 2012

Researchers have successfully interrupted the transmission of river blindness in Escuintla, Guatemala, one of the largest endemic areas in the Western Hemisphere. This achievement marks an important victory in the campaign to eliminate the devastating disease, with eight out of 13 endemic study areas having already ended transmission.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateMar 30, 2009

Flexible, transparent supercapacitors are latest devices from USC nanotube lab

Researchers at the University of Southern California have created a new type of supercapacitor that is both transparent and flexible, allowing for potential applications in 'e-paper' displays and conformable products. The device stores an energy density of 1.29 Watt-hour/kilogram, significantly higher than conventional capacitors.

SourceUniversity of Southern California·JournalApplied Physics Letters·DateMar 30, 2009

GUMC researcher creates first Web-interactive CME course for physicians on pharmaceutical marketing

A new web-based CME course created by PharmedOut aims to educate physicians about the many ways pharmaceutical companies attempt to influence their knowledge of drugs and prescribing behavior. The 'Pharmalyzer' course provides compelling evidence to illustrate the influence of marketing, including disease branding and detailing tactics.

The clinical availability of CT colonography

A study published in the World Journal of Gastroenterology found that CT colonography detected extracolonic lesions in 57.8% of subjects, with highly significant lesions present in 8.7% and low significant lesions in 55.2%. Factors such as age, sex, symptoms, and contrast use were associated with detection of more significant lesions.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 30, 2009

New approach discovered to lowering triglycerides

Researchers at Oregon State University found that lipoic acid supplements can significantly reduce triglyceride levels in laboratory rats, lowering them by up to 60 percent. This natural compound may offer a new way to lower blood triglycerides and reduce the risk of atherosclerosis.

SourceOregon State University·JournalArchives of Biochemistry and Biophysics·DateMar 30, 2009

Eye cells believed to be retinal stem cells are misidentified

Researchers at St. Jude Children's Research Hospital have found that cells isolated from the eye are not retinal stem cells, contradicting previous findings. Instead, they suggest that re-engineering stem cells to develop photoreceptor cells could be a promising approach to restore vision in people with retinal degeneration.

SourceSt. Jude Children's Research Hospital·JournalProceedings of the National Academy of Sciences·DateMar 30, 2009

Heart failure risk model validated

Researchers at Emory University School of Medicine developed the Health ABC Heart Failure Model to predict risk of new onset heart failure in the elderly. The model, validated with a separate library of patient data, identifies high-risk individuals for targeted interventions.

A new molecular marker of gastric cancer

Researchers found that phosphatase regenerating liver 3 (PRL-3) is a new independent prognostic indicator for gastric cancer, predicting tumor recurrence and survival rates. Positive PRL-3 expression was associated with advanced TNM stages, lymph node metastasis, and poorer overall survival rates.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateMar 30, 2009

Study examines the use of light in medical therapy

A study published in Photochemistry and Photobiology explores the potential of light-sensitive drug delivery systems for targeted therapy. The research reveals that near-infrared light can trigger medication release without causing significant heating or damaging surrounding tissues.

SourceWiley·JournalPhotochemical & Photobiological Sciences·DateMar 30, 2009

Stem cell breakthrough: Monitoring the on switch that turns stem cells into muscle

A team of American researchers has developed a genetic switch that allows mutations or light signals to be turned on in muscle stem cells, enabling monitoring of muscle regeneration in living mammals. This breakthrough could lead to the creation of a genetic switch or drug for humans to grow new muscle cells and treat muscular dystrophy.